These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33540830)

  • 1. Combination Regimens of Favipiravir Plus Interferon Alpha Inhibit Chikungunya Virus Replication in Clinically Relevant Human Cell Lines.
    Franco EJ; Tao X; Hanrahan KC; Zhou J; Bulitta JB; Brown AN
    Microorganisms; 2021 Feb; 9(2):. PubMed ID: 33540830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus.
    Franco EJ; Pires de Mello CP; Brown AN
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines.
    Franco EJ; Rodriquez JL; Pomeroy JJ; Hanrahan KC; Brown AN
    Antivir Chem Chemother; 2018; 26():2040206618807580. PubMed ID: 30354193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens.
    Pires de Mello CP; Tao X; Kim TH; Bulitta JB; Rodriquez JL; Pomeroy JJ; Brown AN
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a.
    Gallegos KM; Drusano GL; D Argenio DZ; Brown AN
    J Infect Dis; 2016 Oct; 214(8):1192-7. PubMed ID: 27496974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM).
    Pires de Mello CP; Drusano GL; Rodriquez JL; Kaushik A; Brown AN
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29890736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model.
    Pires de Mello CP; Tao X; Kim TH; Vicchiarelli M; Bulitta JB; Kaushik A; Brown AN
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favipiravir Inhibits Zika Virus (ZIKV) Replication in HeLa Cells by Altering Viral Infectivity.
    Franco EJ; Hanrahan KC; Brown AN
    Microorganisms; 2023 Apr; 11(5):. PubMed ID: 37317071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
    Akhrymuk I; Lukash T; Frolov I; Frolova EI
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination.
    Briolant S; Garin D; Scaramozzino N; Jouan A; Crance JM
    Antiviral Res; 2004 Feb; 61(2):111-7. PubMed ID: 14670584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral.
    Delang L; Segura Guerrero N; Tas A; Quérat G; Pastorino B; Froeyen M; Dallmeier K; Jochmans D; Herdewijn P; Bello F; Snijder EJ; de Lamballerie X; Martina B; Neyts J; van Hemert MJ; Leyssen P
    J Antimicrob Chemother; 2014 Oct; 69(10):2770-84. PubMed ID: 24951535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon Regulatory Factor 1 Protects against Chikungunya Virus-Induced Immunopathology by Restricting Infection in Muscle Cells.
    Nair S; Poddar S; Shimak RM; Diamond MS
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
    Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
    Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favipiravir Suppresses Zika Virus (ZIKV) through Activity as a Mutagen.
    Franco EJ; Cella E; Tao X; Hanrahan KC; Azarian T; Brown AN
    Microorganisms; 2023 May; 11(5):. PubMed ID: 37317316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity of nobiletin against chikungunya virus in vitro.
    Lin SC; Chen MC; Li S; Lin CC; Wang TT
    Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by
    Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond Members of the
    Ferreira AC; Reis PA; de Freitas CS; Sacramento CQ; Villas Bôas Hoelz L; Bastos MM; Mattos M; Rocha N; Gomes de Azevedo Quintanilha I; da Silva Gouveia Pedrosa C; Rocha Quintino Souza L; Correia Loiola E; Trindade P; Rangel Vieira Y; Barbosa-Lima G; de Castro Faria Neto HC; Boechat N; Rehen SK; Brüning K; Bozza FA; Bozza PT; Souza TML
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Real-Time Cell Analysing (RTCA) method as a fast and accurate screen for the selection of chikungunya virus replication inhibitors.
    Marlina S; Shu MH; AbuBakar S; Zandi K
    Parasit Vectors; 2015 Nov; 8():579. PubMed ID: 26553263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of silymarin against chikungunya virus.
    Lani R; Hassandarvish P; Chiam CW; Moghaddam E; Chu JJ; Rausalu K; Merits A; Higgs S; Vanlandingham D; Abu Bakar S; Zandi K
    Sci Rep; 2015 Jun; 5():11421. PubMed ID: 26078201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.